If I Use a Donor Egg, Will the Baby Have My DNA?

A baby conceived through donor egg will carry the nuclear DNA of the egg donor and the sperm provider, not the gestational mother’s nuclear DNA. That much is straightforward genetics. But the full biological picture is far more interesting than a simple “no.” The pregnant person’s body actively communicates with the developing embryo in ways that influence which genes get turned on and off, exchanges cells that persist in both bodies for years, and shapes the baby’s development through molecular signals that researchers are only beginning to catalog. None of this rewrites the baby’s genetic code, but it means the gestational mother’s biological contribution is real, measurable, and more significant than many people assume.

What “Having Your DNA” Actually Means in This Context

When people ask whether a donor-egg baby will have their DNA, they usually mean one of two things. The first is whether the child will carry their chromosomes and inherit their traits through the usual parent-to-child genetic pathway. The answer to that is no. The 23 pairs of chromosomes in the baby’s cells come from the egg donor and the sperm provider. Eye color, blood type, inherited disease risk, and other traits governed by nuclear DNA trace back to those two genetic contributors. Research on ooplasmic transplantation, a related procedure, confirmed through genetic fingerprinting that nuclear DNA was not inherited from the donor in either placental tissue or fetal cord blood, reinforcing how firmly nuclear DNA tracks with the egg and sperm sources.¹

The second meaning, though, is broader: does the gestational mother leave any biological mark on the child? Here the answer is a clear yes, through mechanisms including epigenetic modification, microRNA transfer, microchimerism, and the sheer physical reality that every molecule the embryo uses to grow during nine months of development passes through the pregnant person’s body. These influences do not change the letters of the genetic code, but they can change how that code is read, and some of those changes may last a lifetime.

How the Uterine Environment Shapes Gene Expression

Your genes are not destiny in the way most people imagine. Genes need to be switched on at the right time and in the right tissue to have any effect, and the signals that control that switching are heavily influenced by the environment. In pregnancy, that environment is the uterus. The molecules floating in uterine fluid, the hormonal milieu, the nutrients and even the stress hormones circulating in the mother’s blood all participate in a process called epigenetic programming.

Researchers have proposed that the uterine fluid carries molecules that mirror the mother’s environmental exposure and relay that information to the embryo, generating long-term epigenetic effects on the offspring through embryonic and placental programming.² In plain terms, this means the pregnant person’s diet, stress levels, and overall health can affect which of the baby’s genes become more or less active. The DNA sequence stays the same, but the chemical tags attached to it, which tell the cellular machinery how loudly to read a gene, can shift.

One of the more striking discoveries in this area involves tiny molecules called microRNAs. A study published in Human Reproduction found that human blastocysts efficiently took up small vesicles secreted by endometrial cells within one to two hours, with the uptake concentrated at the hatching pole of the embryo. Analysis identified 149 annotated microRNAs in those vesicles, of which 37 were considered most relevant to implantation.³ These microRNAs are not junk. They are regulatory molecules that can silence or amplify gene activity. The gestational mother’s uterine lining is, in effect, sending molecular instructions to the embryo before it even implants. In a donor-egg pregnancy, those instructions come from the gestational mother, not the egg donor.

This does not mean the gestational mother is rewriting the baby’s genome. She is influencing how that genome is interpreted, which is a meaningful biological distinction. Think of it this way: the donor provides the sheet music, but the gestational mother’s body has a say in how the orchestra plays it.

Microchimerism and the Exchange of Living Cells

During every pregnancy, small numbers of cells cross the placental barrier in both directions. Fetal cells end up in the mother’s bloodstream, and maternal cells migrate into the fetus. These cells can persist for decades in both bodies, a phenomenon called microchimerism. In donor-egg pregnancies, this exchange still occurs, which means the gestational mother’s cells are physically present in the child’s body, and the child’s cells are physically present in hers, even though the two share no nuclear DNA.⁴

The long-term effects of microchimerism are still being studied. In general pregnancy research, maternal cells found in offspring tissue have been implicated in both protective immune functions and, more rarely, autoimmune complications. What makes donor-egg pregnancies unusual is that the fetal cells entering the mother and the maternal cells entering the fetus are completely genetically foreign to each other, rather than sharing half their DNA as in a typical pregnancy. This higher degree of genetic mismatch does not prevent the exchange from happening, but it does raise questions about whether the immune and health consequences differ, and that research is still in early stages.

The Immune Balancing Act in Donor Egg Pregnancy

In a typical pregnancy, the fetus shares half its DNA with the mother, which helps the maternal immune system tolerate its presence. In a donor-egg pregnancy, the entire fetal genome is genetically foreign to the mother. The degree of genetic mismatch is comparable to what you would see in a solid organ transplant from an unrelated donor.⁵ And yet the pregnancy typically proceeds. The mother’s immune system does not reject the fetus, which has made donor-egg pregnancy a genuinely fascinating model for researchers studying immune tolerance.

The maternal immune system has to work harder to achieve this tolerance, and the process is not always seamless. Systematic reviews have found that donor-egg pregnancies carry a higher rate of certain complications, particularly preeclampsia, which is a blood pressure disorder tied to immune and vascular dysfunction at the placental interface.⁶ The fully foreign fetal genome appears to demand a stronger immunological adaptation than a half-shared one.⁷

This is an important practical point for anyone pursuing donor-egg IVF. The immune dynamics of the pregnancy are genuinely different from a standard conception, not just theoretically but in terms of clinical risk. Close monitoring is standard practice, and awareness of the elevated preeclampsia risk is one reason why reproductive endocrinologists treat donor-egg pregnancies with extra attention.

How the Placenta Reflects the Gestational Mother’s Influence

The placenta is often treated as a passive barrier, but it is one of the most active organs in the body during pregnancy. In donor-egg pregnancies, the placenta develops from the fertilized donor egg, so its genetic code belongs to the embryo, not the gestational mother. Yet the mother’s uterine environment profoundly affects how that placenta develops and functions.

Research comparing placentas from donor-egg pregnancies with those from standard IVF and natural conceptions has found differences in the expression of genes related to blood vessel growth. One study found that the type of endometrial preparation used for the embryo transfer affected the expression of placental angiogenic biomarkers: natural cycles showed higher expression of growth-promoting factors, while artificial hormone cycles led to increased expression of factors that restrict blood vessel formation.⁸ In other words, the gestational mother’s hormonal state at the time of transfer left a measurable mark on how the placenta built its blood supply.

Separate research has highlighted that donor-egg pregnancies combine two potential sources of epigenetic disruption: the epigenetic status encoded in the donated egg and the conditions of the uterine environment the embryo develops in. The interaction between these two influences can affect placental gene activity in ways that differ from both naturally conceived pregnancies and standard IVF.⁹ The placenta, then, is a living record of both the donor’s genetics and the gestational mother’s biology.

Genomic Imprinting and Assisted Reproduction

There is a specific subset of genes whose behavior depends on which parent they came from. These “imprinted” genes are chemically tagged during egg and sperm development so that only the maternal or paternal copy is active. Imprinting is regulated by DNA methylation, a chemical process that is sensitive to environmental conditions during the earliest stages of embryo development.

Research has shown that assisted reproductive technology procedures can affect the methylation patterns that control imprinting.¹⁰ This is relevant to donor-egg pregnancies because the embryo goes through critical reprogramming steps while in the laboratory dish and then again after transfer into the uterus. The uterine environment during those early days and weeks can influence how firmly certain imprinting marks are set. Imprinting disorders are rare in the general IVF population, but they have been reported at slightly higher rates than in naturally conceived children, and this is one of the areas where the gestational mother’s biology intersects with the embryo’s epigenetic setup in a potentially consequential way.

Mitochondrial DNA Belongs to the Egg Donor

There is one type of DNA that is often left out of popular discussions of donor-egg conception: mitochondrial DNA. Mitochondria are the structures inside cells that generate energy, and they carry their own small genome, separate from the nuclear DNA in chromosomes. Mitochondrial DNA is inherited exclusively through the egg.¹¹ In a donor-egg pregnancy, the child inherits the egg donor’s mitochondrial DNA, not the gestational mother’s.

This matters in a few specific situations. If the gestational mother carries a mitochondrial disease, the child will not inherit it, because the mitochondria came from the donor. If the egg donor carries a mitochondrial mutation, the child could inherit that condition. Mitochondrial DNA also plays a role in ancestry testing. Because it passes from mother to child in an unbroken line, a child conceived with a donor egg will trace their maternal mitochondrial lineage back to the donor, not to the woman who carried and gave birth to them. This can be surprising for families who take commercial DNA tests years later.

For families where mitochondrial disease is a concern on the intended mother’s side, donor-egg conception actually sidesteps the problem entirely. Mitochondrial replacement therapy, a separate and more experimental approach, was developed specifically for cases where the intended mother wants to contribute her nuclear DNA but needs to avoid passing on defective mitochondria. That procedure involves transferring the mother’s nuclear DNA into a donor egg whose mitochondria are healthy, resulting in a child with three genetic contributors.¹² Standard donor-egg IVF does not involve this step.

Will the Baby Look Like the Gestational Mother?

Physical appearance is controlled primarily by nuclear DNA, so a donor-egg child’s features will reflect the genetics of the egg donor and the sperm provider. If the intended father provides the sperm, the child may resemble him. If the egg donor was selected for physical similarity to the gestational mother, as many families request, the child may appear to resemble her as well, though this is a function of donor selection rather than biological influence.

That said, the epigenetic modifications discussed earlier can have subtle effects on physical development. Gene expression patterns influenced by the uterine environment affect things like birth weight, growth rate, and possibly some aspects of metabolic and cardiovascular development into later life. Some ART research has suggested that the vascular system may be affected by the conditions of conception and early development, and longer follow-up studies are being pursued to understand whether these effects persist.¹³ These are not appearance traits in the way most people think about resemblance, but they are measurable biological outcomes shaped by the gestational mother’s body.

The Emotional Side of a Non-Genetic Connection

For many intended mothers, the question about DNA is really a question about connection. Will I feel like this baby’s mother? Will the child feel like mine? Research on this is reassuring. A qualitative study of egg-donation mothers found that they used a range of strategies across the transition to parenthood that enabled them to establish their identity as the child’s mother. Most felt secure and confident in that identity by the end of the first year. The absent genetic connection varied in significance between mothers, with some barely thinking about it and others actively working through ambivalence, but the majority adjusted successfully.¹⁴

A longitudinal study following egg-donation mothers from pregnancy through early motherhood found a similar pattern. The prenatal bond that developed during pregnancy and the experience of early parental care helped mothers accept the absence of a genetic link. Initial perceptions about the importance of genetic connection changed over the course of pregnancy and after childbirth, with the lived experience of carrying and caring for the baby reshaping those beliefs.¹⁵

The biology described throughout this article supports what these mothers reported feeling: carrying a pregnancy is a profoundly active biological process, not a passive incubation. The gestational mother’s body communicates with the embryo, exchanges cells with it, shapes its gene expression, builds and nourishes its placenta, and adapts its own immune system to protect it. That none of this involves sharing nuclear DNA does not make it less real, and for many mothers, understanding the science behind the connection they feel is itself a source of comfort.

What Direct-to-Consumer DNA Tests Will and Will Not Show

If your donor-egg child eventually takes a consumer ancestry or health test, the results will reflect the egg donor’s and sperm provider’s genetic backgrounds. Ancestry estimates, health risk assessments, and trait predictions are all based on nuclear and mitochondrial DNA, so the gestational mother will not appear in those results. This is worth knowing in advance, because it can be jarring for families who have not discussed the child’s donor origins, and it has become an increasingly common way for donor-conceived people to discover the circumstances of their conception.

The epigenetic influence of the gestational mother is invisible to current commercial tests. No consumer product on the market measures the methylation patterns or microRNA signatures that reflect the uterine environment’s contribution. Researchers can detect these influences in specialized laboratory settings, but they are not part of any consumer health report. So while the gestational mother’s biological contribution is scientifically real, it will not show up on a 23andMe or AncestryDNA readout. Understanding this gap between what the science shows and what the test reports is useful for managing expectations and planning conversations within the family.